2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿|IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Blood Advances BLOOD ADV (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.2
53人评分
我要评分
声誉 8.8 影响力 6.1 速度 7.0 | |||||||||||||||||||||
| 期刊ISSN | 2473-9529 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 2473-9537 | |||||||||||||||||||||
| 2024-2025最新影响因子 (数据来源于搜索引擎) | 7.1 点击查看影响因子趋势图 | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:7.6 | |||||||||||||||||||||
| 2024-2025自引率 | 4.2%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年影响因子 | 7.1 | |||||||||||||||||||||
| JCI期刊引文指标 | 1.88 | |||||||||||||||||||||
| h-index | 暂无h-index数据 | |||||||||||||||||||||
| CiteScore ( 2025年最新版) |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://www.journals.elsevier.com/blood-advances | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | ||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | TNIK as a molecular switch regulating platelet function in hemostasis and hyperlipidemia-associated thrombosis Author: Li, Li; Chen, Xiaoyan; Li, Jingke; Deng, Xin; Sheng, Yilin; Lu, Linrong; Hu, Hu Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 6, pp. 1864-1878. DOI: 10.1182/bloodadvances.2025017737 Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A mice Author: Yu, Hongyin; Schroeder, Jocelyn A.; Mattson, Jeremy G.; Gao, Chunyan; Shi, Qizhen Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 6, pp. 1883-1896. DOI: 10.1182/bloodadvances.2025017921 Efficacy and safety of selinexor combined with VRD in newly diagnosed multiple myeloma with EMD: a phase 2 trial Author: Jin, Yuanyuan; Cheng, Xin; Zhang, Xuezhong; Shi, Qinglin; Zhu, Yu; Li, Jianyong; Fan, Lei; Chen, Lijuan Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 6, pp. 2016-2022. DOI: 10.1182/bloodadvances.2025018945 Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming Author: Carminita, Estelle; Camacho, Virginia; Branfield, Siobhan; Walsey, Ethan; Barrachina, Maria N.; Tabang, Dylan N.; Lee, Dong H.; Becker, Isabelle C.; V. Brodsky, Sergey; Issa, Samer M.; Gendron, Nicolas; Machado, Sarah; Wolberg, Alisa S.; Steen, Hanno; Kerlin, Bryce; Machlus, Kellie R.; Zarjou, Abolfazl; Italiano, Joseph E Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 5, pp. 1444-1456. DOI: 10.1182/bloodadvances.2025017625 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Blood Advances的语言要求,还能让Blood Advances编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Blood Advances编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | 2021 L ST NW, SUITE 900, WASHINGTON, USA, DC, 20036 | |||||||||||||||||||||
| 出版商 | American Society of Hematology | |||||||||||||||||||||
| 涉及的研究方向 | Medicine-Hematology | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 492点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 98.94% | |||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 96.14% | |||||||||||||||||||||
| WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) 中科院的全球OA期刊索引(OAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2473-9529%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验: | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Blood Advances顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
| |
| 中国学者近期发表的论文 | |
| 1. | TNIK as a molecular switch regulating platelet function in hemostasis and hyperlipidemia-associated thrombosis Author: Li, Li; Chen, Xiaoyan; Li, Jingke; Deng, Xin; Sheng, Yilin; Lu, Linrong; Hu, Hu Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 6, pp. 1864-1878. DOI: 10.1182/bloodadvances.2025017737 PubMed DOI |
| 2. | Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A mice Author: Yu, Hongyin; Schroeder, Jocelyn A.; Mattson, Jeremy G.; Gao, Chunyan; Shi, Qizhen Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 6, pp. 1883-1896. DOI: 10.1182/bloodadvances.2025017921 PubMed DOI |
| 3. | Efficacy and safety of selinexor combined with VRD in newly diagnosed multiple myeloma with EMD: a phase 2 trial Author: Jin, Yuanyuan; Cheng, Xin; Zhang, Xuezhong; Shi, Qinglin; Zhu, Yu; Li, Jianyong; Fan, Lei; Chen, Lijuan Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 6, pp. 2016-2022. DOI: 10.1182/bloodadvances.2025018945 PubMed DOI |
| 4. | Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming Author: Carminita, Estelle; Camacho, Virginia; Branfield, Siobhan; Walsey, Ethan; Barrachina, Maria N.; Tabang, Dylan N.; Lee, Dong H.; Becker, Isabelle C.; V. Brodsky, Sergey; Issa, Samer M.; Gendron, Nicolas; Machado, Sarah; Wolberg, Alisa S.; Steen, Hanno; Kerlin, Bryce; Machlus, Kellie R.; Zarjou, Abolfazl; Italiano, Joseph E Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 5, pp. 1444-1456. DOI: 10.1182/bloodadvances.2025017625 PubMed DOI |
| 5. | Inhibition of NAMPT targets DNA damage response to sensitize alkylating chemotherapy in TP53 mutant mantle cell lymphoma Author: Li, Na; Liu, Yicen; Zhang, Linna; Guo, Saisai; Wu, Zhihao; Xu, Yan; Yang, Ming; Kong, Jixia; Che, Yuxuan; Shao, Kun; Yang, Hong Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 5, pp. 1722-1732. DOI: 10.1182/bloodadvances.2025016765 PubMed DOI |
| 6. | Clonal hematopoiesis may precede the diagnosis of aplastic anemia by several years Author: Liu, Qianwei; Fang, Fang; Xue, Huiwen; Wasterlid, Tove; Smedby, Karin Ekstrom; Liu, Xinyuan Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 4, pp. 1293-1300. DOI: 10.1182/bloodadvances.2024015776 DOI |
| 7. | Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencing Author: Fang, Baijun; Zhu, Zunmin; Chang, Yinyin; He, Xiangxiang; Li, Shiyong; Li, Manqian; Yan, Susu; Zhu, Dandan; Li, Zhenling; Mao, Mao Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 4, pp. 1312-1323. DOI: 10.1182/bloodadvances.2025018133 DOI |
| 8. | Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults Author: Xie, Yan; Zhou, Ke-Shu; Li, Lan-Fang; Liang, Ai-Bin; Mei, Heng; Zou, De-hui; Li, Wen-Yu; Jin, Jie; Jin, Zheng-Ming; Jing, Hong-Mei; Yang, Hai-Yan; Chen, Tong; Huang, Hui-Qiang; He, Peng-Cheng; Cao, Jun-Ning; Xia, Zhen; Gu, Yong-En; Zang, Yi-Bei; Zhou, Zi-Song; Tian, Zhao-Zhao; Zhu, Jun; Song, Yu-Qin Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 4, pp. 1134-1144. DOI: 10.1182/bloodadvances.2024015763 DOI |
| 9. | Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy Author: Wei, Andrew H.; Panayiotidis, Panayiotis; Montesinos, Pau; Laribi, Kamel; Ivanov, Vladimir; Kim, Inho; Novak, Jan; Champion, Rebecca; Fiedler, Walter; Pagoni, Maria; Bergeron, Julie; Ting, Stephen B.; Hou, Jing-Zhou; Yamauchi, Takahiro; Wang, Jianxiang; Strickland, Stephen A.; Savona, Michael R.; Lin, Tara L.; Enjeti, Anoop; Tiong, Ing Soo; Lee, Sangmin; Roboz, Gail J.; Popovic, Relja; Jiang, Qi; Liu, Zihuan; Sun, Yan; Mendes, Wellington; Chyla, Brenda; Dinardo, Courtney D Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 4, pp. 987-998. DOI: 10.1182/bloodadvances.2025017083 PubMed DOI |
| 10. | Vulnerability of SRSF2-mutated chronic myelomonocytic leukemia to perturbation of the cGAS-STING pathway Author: Chen, Yanan; Chan, Koon Chuen; Sin, Chun Fung; Zheng, Lichuan; Wang, Dandan; Tu, Lingge; He, Fangfang; Hui, Wan Hei Jeffrey; Leung, Hoi Ki; Chan, Leslie Kar Fai; Tsui, Sze Pui; Chan, Hoi Yi; Ma, Alvin Chun Hang; Leung, Anskar Y. H.; Sun, Xuan Journal: BLOOD ADVANCES. 2026; Vol. 10, Issue 3, pp. -. DOI: 10.1182/bloodadvances.2025017005 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共1条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室